Impact of Transfusional Practice on the Morbidity and Mortality of Patients in Intensive Care Unit
PATMORE
1 other identifier
observational
150,000
1 country
1
Brief Summary
This study will allow correlating transfusion monitoring and patients' prognostic according to the chosen outcome criteria. These data could thus represent a basis for transfusion recommendations, except for intensive care and vital emergencies. It will also bring information about the actual transfusion monitoring in intensive care unit (ICU), in the period following the stay in the ICU and after hospital discharge.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 26, 2019
CompletedFirst Posted
Study publicly available on registry
May 1, 2019
CompletedStudy Start
First participant enrolled
January 3, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
September 19, 2024
September 1, 2024
6.9 years
April 26, 2019
September 5, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Survival at 90 days after leaving ICU
All-cause mortality 90 days after leaving ICU
Day 90
Eligibility Criteria
All patients treated in medical and surgical resuscitation units of Besançon and Dijon university hospitals during the study period (from 01/01/2012 to 31/12/2017) are concerned.
You may qualify if:
- Patient admitted to medical and surgical resuscitation units of Besançon and Dijon university hospitals, all causes considered
- Patient admitted between 1st January 2012 to 31st December 2017
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU de Besançon
Besançon, France
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 26, 2019
First Posted
May 1, 2019
Study Start
January 3, 2020
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
September 19, 2024
Record last verified: 2024-09